Azenta, Inc. (LON: 0HQ1)
London
· Delayed Price · Currency is GBP · Price in USD
54.00
-0.45 (-0.83%)
Jan 23, 2025, 2:35 PM BST
Azenta Revenue
In the fiscal year ending September 30, 2024, Azenta had annual revenue of $656.32M USD, down -1.32%. Azenta had revenue of $170.06M in the quarter ending September 30, 2024, a decrease of -1.33%.
Revenue
$656.32M
Revenue Growth
-1.32%
P/S Ratio
n/a
Revenue / Employee
$198.89K
Employees
3,300
Market Cap
2.00B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 656.32M | -8.75M | -1.32% |
Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Azenta News
- 6 weeks ago - Azenta Inc (AZTA) Trading Down 3.29% on Dec 5 - GuruFocus
- 2 months ago - Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 - PRNewsWire
- 2 months ago - Azenta to Participate in Stephens Annual Investment Conference - PRNewsWire
- 2 months ago - Azenta, Inc. (AZTA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO - PRNewsWire
- 2 months ago - Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast - PRNewsWire
- 2 months ago - Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value - PRNewsWire
- 3 months ago - Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test - PRNewsWire